AUBREY CLAXTON: Open Payments
NPI 1700592722 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $207 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VYNDAQEL, REPATHA, Wegovy, Kerendia, CAMZYOS.
Industry payments across GA — which companies pay providers there.
